Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 853.51M | 1.38B | -199.27M | -199.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 853.51M | 1.38B | -199.27M | -199.24M |
| Cost of Revenue | -- | 581.87M | 992.58M | -290.41M | -290.35M |
| Gross Profit | -- | 271.64M | 392.04M | 91.14M | 91.11M |
| SG&A Expenses | -- | 201.62M | 289.31M | 33.49M | 33.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -6.15M | -2.11M | 1.59M | 1.36M |
| Total Operating Expenses | -- | 777.34M | 1.28B | -255.34M | -255.45M |
| Operating Income | -- | 76.17M | 104.84M | 56.06M | 56.20M |
| Income Before Tax | -- | 85.87M | 93.45M | 89.80M | 89.48M |
| Income Tax Expenses | -- | 6.99M | 4.35M | -1.71M | -1.82M |
| Earnings from Continuing Operations | -- | 78.88 | 89.10 | 91.50 | 91.30 |
| Earnings from Discontinued Operations | -- | 85.54M | 85.54M | 16.10M | 16.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 227.00K | 277.00K | 234.00K | 190.00K |
| Net Income | -- | 164.64M | 174.92M | 92.23M | 91.88M |
| EBIT | -- | 76.17M | 104.84M | 56.06M | 56.20M |
| EBITDA | -- | 194.95M | 256.68M | 178.97M | 179.11M |
| EPS Basic | -- | 0.37 | 0.39 | 0.21 | 0.21 |
| Normalized Basic EPS | -- | 0.09 | 0.13 | 0.17 | 0.17 |
| EPS Diluted | -- | 0.37 | 0.39 | 0.21 | 0.21 |
| Normalized Diluted EPS | -- | 0.09 | 0.13 | 0.17 | 0.17 |
| Average Basic Shares Outstanding | -- | 1.83B | 1.82B | 1.85B | 1.84B |
| Average Diluted Shares Outstanding | -- | 1.83B | 1.82B | 1.85B | 1.84B |
| Dividend Per Share | -- | -- | -- | 0.06 | 0.06 |
| Payout Ratio | -- | 18.22% | 17.15% | 43.37% | 43.54% |